Projects

Browse through our collection of selected research projects and discover the diversity of European cooperation in Lower Saxony!

UMG scientist receives highest European award for early career researchers

Prof. Dr Hauke Hillen, head of the “Structure and Function of Molecular Machines” working group at the Institute of Cell Biochemistry at the University Medical Center Göttingen (UMG), independent research group leader at the Max Planck Institute (MPI) for Multidisciplinary Sciences and member of the Cluster of Excellence “Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells” (MBExC), will use the funding to investigate how the powerhouses of cells – the mitochondria – produce proteins.

ERC Grant for Prof. Philippe van Basshuysen’s studies on the influence of scientific models on reality

On 1 February 2024, a new ERC Starting Grant was started at Leibniz University Hannover (LUH). Prof. Dr. Philippe van Basshuysen has received the prestigious European Union funding to spend the coming five years researching how scientific models not only reflect the world but can also change it. His project MAPS – Managing Performative Science also develops strategies for dealing with this phenomenon in a better way.

Lukas Hakelberg receives ERC grant for his research on the emergence of tax havens in the Global South

The ERC has awarded Prof. Dr. Lukas Hakelberg a Starting Grant for his project entitled “The Whiteness of Wealth Management: Colonial Economic Structure, Racism, and the Emergence of Tax Havens in the Global South (WOWMA)”. During its runtime, he will analyse the development of tax havens with a focus on colonial economic structures, income tax adoption, the survival of white oligarchies, and racism.

From the lab to the market: enabling bone repair

When bones fail to heal – for example after an accident or cancer treatment – bone defects remain, placing a burden on patients as well as society and the economy. “Worldwide, more than four million operations per year require bone grafts or substitutes. At the same time, current treatment options are limited.